Overview Technical Risk & rank Quality Results Accounts Filings Options Guidance & governance
Filings
37 filings of COROMANDEL since December 2024.
board outcome 12, presentation 10, transcript 7, dividend 4, results 2, credit rating 2
| Filed | Type | Subject | |
|---|---|---|---|
| 11 Nov 2026 | presentation | Coromandel International Limited has informed the Exchange about Investor PresentationAI summaryCoromandel International has filed an intimation that its investor presentation for the Q2 and H1FY27 results conference call is uploaded on its website. The conference call to discuss results for the quarter and half-year ended September 30, 2026 is scheduled for November 12, 2026 at 11:00 AM (IST). The filing is an intimation under Regulation 46(2)(o) of the SEBI LODR Regulations, 2015 and refers to earlier letter ref. no. 2026-27/048 dated November 8, 2026. The presentation pages provided do not include any financial figures or management commentary. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 06 Nov 2026 | board outcome Acquisition, Legal, Management change, Results | Coromandel International Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.AI summaryBoard of Coromandel International approved the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026, with a limited review report from statutory auditors S R Batliboi & Associates LLP (figures not included in the pages provided). Board approved re-appointment of Mr. Sudarshan Venu (DIN: 03601690) as Independent Director for a second five-year term from February 3, 2027 to February 2, 2032, subject to shareholder approval by special resolution through postal ballot. Board approved the postal ballot notice and fixed November 6, 2026 as the cut-off date for dispatch of the notice and e-voting rights. Board noted completion of conversion of a USD 9.70 million loan into equity shares of Baobab Mining and Chemicals Corporation S A, a step-down subsidiary held through Coromandel Chemicals Limited (1,11,355 equity shares at USD 87.11 per share; related party transaction approved on July 23, 2026). The board meeting ran from 1:00 p.m. to 3:00 p.m. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 31 Jul 2026 | transcript Capex, Guidance, Results | Coromandel International Limited has informed the Exchange about TranscriptAI summaryCoromandel International filed the transcript of its Q1 FY27 earnings conference call held on July 24, 2026, uploaded on its website under Regulation 46(2)(oa)(ii) of the SEBI LODR Regulations. Management (MD & CEO S. Sankarasubramanian) said fertilizer production was moderated to 6.9 lakh tons from 8.4 lakh tons (about 72% capacity utilization) to optimise inventory amid volatile raw material prices, and that NBS subsidy rates rose about 10% but do not fully offset higher raw material costs. Management reported consolidated total income of INR8,215 crores (up 15% from INR7,126 crores) and consolidated EBITDA of INR761 crores (down 3% from INR782 crores) for the quarter, with net profit of INR382 crores versus INR502 crores last year (CFO Deepak Natarajan). Management said the crop protection business delivered record Q1 revenue of INR870 crores (up 20%) and EBIT of INR159 crores (up 44%), and that the retail business revenue rose 85% year-on-year. Management said the granulation project is on track for commissioning in Q4 of this year and capacity expansion of key crop protection molecules is expected by September. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 24 Jul 2026 | presentation Results | Coromandel International Limited has informed the Exchange about Investor PresentationAI summaryCoromandel International has filed the investor presentation for its Q1FY27 results conference call, held on July 24, 2026 at 02:30 PM (IST). The presentation has been uploaded to the company website as required under Regulation 46(2)(o) of the SEBI LODR Regulations, 2015. The filing is a cover letter from the Company Secretary, B. Shanmugasundaram; the pages provided do not include the presentation's financial figures or management commentary. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 23 Jul 2026 | board outcome Capex, Legal, Results | Coromandel International Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.AI summaryCoromandel International's board approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026 on July 23, 2026; statutory auditors S R Batliboi & Associates LLP issued unmodified limited review reports. Standalone revenue from operations for Q1 FY27 was Rs 7,743.55 crore against Rs 7,001.32 crore a year earlier; standalone net profit after tax was Rs 376.96 crore versus Rs 508.23 crore. Consolidated revenue from operations for the quarter was Rs 8,164.77 crore versus Rs 7,042.30 crore a year earlier; consolidated net profit attributable to owners was Rs 380.82 crore versus Rs 505.01 crore. The board approved conversion of loans of about Rs 108 crore into equity shares of wholly owned subsidiary Coromandel Chemicals Limited at Rs 39.95 per share, and restructuring of USD 9.70 million loans to step-down subsidiary Baobab Mining and Chemicals Corporation SA into equity, preference shares or other mutually agreed instruments. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 15 May 2026 | transcript Acquisition, Capex, Results | Coromandel International Limited has informed the Exchange about TranscriptAI summaryCoromandel International filed the transcript of its Q4 FY26 earnings conference call held on May 8, 2026, for the quarter ended March 31, 2026, uploaded on its website under Regulation 46(2)(oa)(ii) of the SEBI LODR Regulations. Management (MD & CEO S. Sankarasubramanian) said record fertilizer production was 3.5 million tons and record DAP and NPK sales were 4.3 million tons, up 7%. Management said standalone crop protection revenue rose 15% to INR 3,054 crores and profitability rose 55% to INR 569 crores. Management said Nagarjuna Agrichem (NACL) revenue rose 28% to INR 1,585 crores with EBITDA of INR 103 crores against last year's losses. Management said Q4 consolidated revenue grew 19% to INR 6,068 crores and EBITDA grew 16% to INR 494 crores, and it flagged high raw material prices and supply disruption from the Middle East as ongoing challenges. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 08 May 2026 | presentation | Coromandel International Limited has informed the Exchange about Investor PresentationAI summaryCoromandel International has filed the investor presentation for its Q4FY26 results conference call, scheduled for May 8, 2026 at 2:30 PM (IST). The presentation has been uploaded to the company website as required under Regulation 46(2)(o) of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The filing is a cover letter; the presentation content itself is not included in the pages provided, so no financial figures or management commentary can be reported from it. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 07 May 2026 | board outcome Dividend / buy-back, Legal, Results | Coromandel International Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.AI summaryCoromandel International's board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 (auditor S R Batliboi & Associates LLP). Standalone revenue from operations was Rs 30,530.89 million for FY2026 versus Rs 24,064.25 million in FY2025; standalone net profit after tax was Rs 2,008.58 million for FY2026 versus Rs 1,940.90 million. Consolidated revenue from operations was Rs 31,479.54 million for FY2026 versus Rs 24,085.24 million in FY2025; consolidated net profit was Rs 1,898.14 million versus Rs 2,054.71 million. Board declared a final dividend of Rs 2 per equity share (face value Re 1), record date July 16, 2026, payable on or before August 21, 2026; the 64th AGM is set for July 23, 2026. Board approved re-appointment of S R Batliboi & Associates LLP as statutory auditors for a second term of five years, subject to shareholder approval; a corporate guarantee of up to USD 15.5 million for subsidiary Baobab Mining & Chemicals Corporation, Senegal, was also disclosed. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 07 May 2026 | dividend Dividend / buy-back, Legal, Results | Coromandel International Limited has informed the Exchange that Board of Directors at its meeting held on May 07, 2026, recommended Final Dividend of Rs. 2 per equity share.AI summaryCoromandel International's board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 on May 7, 2026. Standalone revenue from operations for FY2026 was Rs 30,530.89 million, against Rs 24,064.25 million in FY2025; standalone net profit after tax was Rs 2,008.58 million for FY2026 versus Rs 1,940.90 million in FY2025. Consolidated net profit after tax for FY2026 was Rs 1,898.14 million, against Rs 2,054.71 million in FY2025. The board declared a final dividend of Rs 2 per equity share of face value Re 1, payable on or before August 21, 2026, with record date July 16, 2026; the 64th AGM is set for July 23, 2026. The board also approved re-appointment of S R Batliboi & Associates LLP as statutory auditors for a second term of five years, subject to shareholder approval, and disclosed a corporate guarantent of up to USD 15.5 million for Baobab Mining & Chemicals Corporation, Senegal, a 71.51%-owned subsidiary, with further details to follow. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 30 Mar 2026 | board outcome Management change | Coromandel International Limited has informed the Exchange regarding Outcome of Board Meeting held on March 30, 2026.AI summaryCoromandel International's board, at its meeting on March 30, 2026, approved redesignating Mr. Narayanan Vellayan from Whole Time Director – Strategic Sourcing to Executive Director – Nutrient Business, effective April 20, 2026, with other appointment terms unchanged. The board noted changes in senior management personnel effective April 20, 2026: Mr. Madhab Adhikari, Mr. Avinash Thakur, Mr. Babu G, Mr. Saurabh Kumar Jain and Mr. Vishal Sharma were designated as senior management personnel due to organisational changes. Mr. Bharat Chaba, Mr. Roshan Mammen and Mr. Amir Alvi ceased to be senior management personnel due to organisational changes; Mr. Amir Alvi (Chief Operating Officer - Fertilizer) resigned and is to be relieved from services at closing hours of April 24, 2026. The board meeting commenced at 10:00 a.m. and concluded at 13:10 p.m. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 09 Feb 2026 | transcript Dividend / buy-back, Guidance, Rating, Results | Coromandel International Limited has informed the Exchange about TranscriptAI summaryCoromandel International filed the transcript of its Q3 FY26 earnings conference call held on February 2, 2026, uploaded to its website under Regulation 46(2)(oa)(iii) of the SEBI LODR Regulations. Management (MD & CEO S. Sankarasubramanian) said Q3 was a tough quarter for the fertilizer industry due to unseasonal rains, higher raw material prices and rupee depreciation, but the business delivered a resilient performance, with the highest ever quarterly fertilizer production of 9.9 lakh tons. CFO Deepak Natarajan reported consolidated total income of INR8,863 crores for the quarter (up 26%) and consolidated EBITDA of INR805 crores against INR722 crores last year; quarterly net profit after tax was INR488 crores against INR508 crores. The board approved an interim dividend of INR9 per equity share (900% on face value of INR1) in its meeting held on January 29, 2026. Management said the Crop Protection & Bio business reported standalone revenue of INR785 crores for the quarter, up 24%, with EBIT up 74% to INR158 crores. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 02 Feb 2026 | presentation | Coromandel International Limited has informed the Exchange about Investor PresentationAI summaryCoromandel International has filed an investor presentation for its conference call on Q3FY26 results (quarter ended December 31, 2025), scheduled for February 2, 2026 at 02:30 PM (IST). The presentation has been uploaded to the company website as required under Regulation 46(2)(o) of the SEBI Listing Obligations and Disclosure Requirements, 2015. The filing is a covering letter; the pages provided do not include the presentation's financial figures or management commentary. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 29 Jan 2026 | board outcome Dividend / buy-back, Results | Coromandel International Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.AI summaryBoard of Coromandel International approved unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025 on January 29, 2026. Standalone revenue from operations for the quarter ended December 31, 2025 was Rs 8,457.33 crore; standalone net profit after tax was Rs 529.71 crore for the quarter and Rs 1,854.27 crore for the nine months. Consolidated revenue from operations for the quarter was Rs 8,779.45 crore; consolidated net profit after tax was Rs 488.47 crore for the quarter. The Board declared an interim dividend of Rs 9 per equity share (900% on face value of Re 1) for FY 2025-26, with a record date of February 4, 2026 and payment on or after February 18, 2026. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 29 Jan 2026 | dividend Dividend / buy-back, Results | Coromandel International Limited has informed the Exchange that Board of Directors at its meeting held on January 29, 2026, declared Interim Dividend of 9 per equity share.AI summaryBoard approved unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, with limited review report from S R Batliboi & Associates. Standalone net profit after tax was Rs 529.71 crore for the quarter and Rs 1,854.27 crore for nine months; standalone revenue from operations was Rs 8,457.33 crore for the quarter and Rs 24,869.99 crore for nine months. Consolidated net profit after tax was Rs 488.47 crore for the quarter and Rs 1,783.50 crore for nine months; consolidated revenue from operations was Rs 8,779.45 crore for the quarter. Board declared interim dividend for FY 2025-26 of Rs 9 per equity share (900% on face value of Re 1), payable on or after February 18, 2026, with record date February 4, 2026. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 01 Dec 2025 | board outcome Acquisition, Capex, Management change | Coromandel International Limited has informed the Exchange regarding Outcome of Board Meeting held on December 01, 2025.AI summaryCoromandel International's board, meeting held December 1, 2025, noted NACL Industries' (listed subsidiary) board approval of a rights issue of up to Rs. 250 Crores and approved subscribing to the full rights entitlement plus additional shares up to Rs. 250 Crores, with a committee to finalise terms. Coromandel's board approved setting up a wholly owned subsidiary in the Philippines with investment of up to USD 200,000. The board noted a change in Coromandel's senior management; details are in Annexure-2, which was not included in the pages provided. NACL's board also approved appointing Mr. N. Shankar as CFO and KMP with effect from December 1, 2025, after the resignation of Mr. Anish Mathew as CFO. Further NACL board approvals include shifting its registered office within Hyderabad and extending by two years the conversion period of Rs. 28 Crores of CCDs issued by NACL Spec-Chem to Coromandel. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 30 Nov 2025 | presentation | Coromandel International Limited has informed the Exchange about Investor PresentationAI summaryCoromandel International has filed an investor presentation for its Investor & Analyst Meet to be held on December 1, 2025. The presentation has been uploaded on the company website, as required under Regulation 46(2)(o) of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. This letter follows the company's earlier letter no. 2025-26/077 dated November 26, 2025 regarding the meet. The filing text does not include the presentation's financial figures or management commentary. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 07 Nov 2025 | transcript Acquisition, Capex, Guidance, Results | Coromandel International Limited has informed the Exchange about TranscriptAI summaryCoromandel International filed the transcript of its Q2 FY26 earnings conference call held on October 31, 2025, uploaded to its website under Regulation 46(2)(oa)(ii) of the SEBI LODR Regulations. Management (MD and CEO Sankarasubramanian S) described a resilient quarter across all business segments, with NPK production of about 9.1 lakh tons, up 3% year on year, and phosphoric acid output up 13%. Management said the Kakinada backward integration project was 90% complete, with commissioning expected in January, and that NPK capacity enhancement there for 1 million tons is likely to finish by Q3 of next year. Management said Coromandel became the largest marketer of phosphatic fertilizers with a 19% consumption-based market share in H1 versus 17% last year, and that crop protection revenue grew 10% to INR 829 crores with EBIT up 48% to INR 162 crores. Management said the NACL Industries acquisition was completed followed by the mandatory open offer, with NACL H1 revenue up 18% to INR 900 crores and EBITDA up 12% to INR 83 crores. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 31 Oct 2025 | presentation | Coromandel International Limited has informed the Exchange about Investor PresentationAI summaryCoromandel International has uploaded its investor presentation for the conference call on Q2 and H1 FY26 results, held on October 31, 2025 at 2:30 PM IST. The filing is a cover letter that references the presentation on the company website and states it was filed under Regulation 46(2)(o) of the SEBI LODR Regulations, 2015. The pages provided do not include the presentation's financial figures or management commentary. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 30 Oct 2025 | board outcome Acquisition, Legal, Management change, Results | Coromandel International Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.AI summaryCoromandel International's board approved unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025, with an unmodified limited review report from S.R. Batliboi & Associates LLP. Standalone revenue from operations for Q2 FY26 was Rs 7,011.34 crore... (as printed: 9,411.34 crore for the quarter ended September 30, 2025, versus 7,001.32 crore in June 2025 and 7,432.31 crore in September 2024); standalone net profit after tax was Rs 816.33 crore for the quarter, versus Rs 695.86 crore a year earlier. Consolidated revenue from operations was Rs 9,654.13 crore for the quarter ended September 30, 2025, and consolidated net profit after tax was Rs 793.44 crore. The board also approved a postal ballot notice to re-appoint Mr. Arun Alagappan as Whole-time Director, designated Executive Chairman, for five years from February 15, 2026 to February 14, 2031, and to seek approval for loans under Section 185 of the Companies Act, 2013. The company also disclosed a letter of comfort for lenders to NACL Industries Limited and its subsidiaries, and an inter-corporate loan to subsidiary NACL Industries Limited. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 30 Oct 2025 | board outcome Acquisition, Legal, Management change, Results | Coromandel International Limited has informed the Exchange regarding Board meeting held on October 30, 2025.AI summaryCoromandel International's board approved unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025, with an unmodified limited review report from S.R. Batliboi & Associates LLP. Standalone revenue from operations for Q2 FY26 was Rs 7,011.34 crore... (as printed: 9,411.34 crore, read with total income of 9,513.26 crore); standalone net profit after tax for the quarter was Rs 816.33 crore versus Rs 695.86 crore a year earlier. Consolidated net profit for the quarter was Rs 793.44 crore (half year Rs 1,295.03 crore), against Rs 659.10 crore in the same quarter last year. The board also approved a postal ballot notice to re-appoint Mr. Arun Alagappan as Whole-time Director, designated Executive Chairman, for five years from February 15, 2026 to February 14, 2031, and to seek approval for loans under Section 185 of the Companies Act, 2013. The company disclosed a letter of comfort for lenders of NACL Industries Limited and its subsidiaries, and an inter-corporate loan to NACL Industries Limited. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 22 Sep 2025 | board outcome Capex, Management change | Coromandel International Limited has informed the Exchange regarding Outcome of Board Meeting held on September 22, 2025.AI summaryThe Board of Coromandel International Limited, at its meeting held on September 22, 2025 (10:25 a.m. to 12:00 noon), approved setting up a Technical Mono Ammonium Phosphate (TMAP) plant at Visakhapatnam. The filing also updates on Senior Management Personnel: Mr. Anirban Deb Ray has been designated as Senior Management Personnel, as General Counsel, effective September 22, 2025, due to organisational changes. Mr. Anirban Deb Ray is a full-time employee of the Company; he has more than 24 years of experience in CS and Legal and was previously with Tata Communications Limited. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 23 Aug 2025 | credit rating Rating | Coromandel International Limited has informed the Exchange about Credit RatingAI summaryIndia Ratings & Research affirmed Coromandel International Limited's ratings in an announcement dated August 22, 2025. Issuer rating: IND AAA/Stable. Bank loan facilities: long-term IND AAA/Stable and short-term IND A1+, rated amount Rs. 2500 Crores. Commercial paper: short-term IND A1+, rated amount Rs. 1000 Crores. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 01 Aug 2025 | transcript Acquisition, Capex, Dividend / buy-back, Results | Coromandel International Limited has informed the Exchange about TranscriptAI summaryCoromandel International filed the transcript of its 1Q FY26 post-results conference call held on July 25, 2025, uploaded to its website under Regulation 46(2)(oa)(ii). Management reported consolidated total income of INR7,126 crores for the quarter versus INR4,783 crores a year earlier, a growth of 49%, and consolidated EBITDA of INR782 crores versus INR506 crores, a growth of 55%. Management said crop protection and bio segments revenue grew 31% to Rs 725 crores and EBIT rose 77% to Rs 111 crores. Management said subsidy claims received during the quarter were INR1,300 crores, with subsidy outstanding at June 30 of INR2,911 crores. Management said the Baobab Mining and Chemicals stake is being raised from 53.8% to 71.5% and a backward integration phosphoric and sulfuric acid project is expected to be commissioned in Q4 of FY26. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 24 Jul 2025 | presentation | Coromandel International Limited has informed the Exchange about Investor PresentationAI summaryCoromandel International has filed an investor presentation for its conference call on Q1FY26 results, scheduled for July 25, 2025 at 2:30 PM (IST). The presentation was uploaded to the company website, as required under Regulation 46(2)(o) of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The filing covers the quarter ended June 30, 2025; the page text provided does not include the presentation's financial figures or management commentary. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 24 Jul 2025 | board outcome Acquisition, Capex, Management change, Results | Coromandel International Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.AI summaryBoard of Coromandel International approved unaudited standalone and consolidated results for the quarter ended June 30, 2025, with an unmodified limited review report from S.R. Batliboi & Associates LLP. Standalone total income for Q1 FY26 was Rs 7,082.92 crore and net profit after tax Rs 508.23 crore, against Rs 4,767.78 crore and Rs 330.96 crore in the year-ago quarter (June 30, 2024). Consolidated total income for the quarter was Rs 7,126.04 crore and consolidated net profit Rs 505.01 crore (attributable to owners Rs 501.59 crore). Board approved acquisition of 17.69% of Baobab Mining and Chemicals Corporation, Senegal, by wholly owned subsidiary Coromandel Chemicals Limited for USD 7.70 million, raising its stake from 53.82% to 71.51%. Board approved capital expenditure for a bagging plant at Kakinada as part of granulation capacity expansion, and noted a change in senior management personnel. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 09 May 2025 | transcript Acquisition, Capex, Dividend / buy-back, Guidance, Management change, Results | Coromandel International Limited has informed the Exchange about TranscriptAI summaryCoromandel International filed under Regulation 30 that the transcript of its Q4 FY25 earnings conference call held on May 2, 2025 has been uploaded to the company website. Management said consolidated total income was Rs 5,114 crores for Q4 (up 28% year on year) and Rs 24,444 crores for FY25 (up 10%); consolidated EBITDA was Rs 426 crores for the quarter and Rs 2,628 crores for the year. Management said the Board approved a final dividend of Rs 9 per share (normal Rs 6 plus special Rs 3). Management said the NACL Industries controlling-stake acquisition awaits regulatory approvals, expected to close by Q2 of FY26, and that the Rs 1,000 crore crop protection/specialty chemicals/CDMO capex plan will be moderated rather than trimmed. Management said the Ma'aden contract covers 300,000 tons per annum of DAP and NPK, with potential to rise to 0.5 million tons. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 02 May 2025 | presentation | Coromandel International Limited has informed the Exchange about Investor PresentationAI summaryCoromandel International has filed the investor presentation for its Q4FY25 results conference call, held on May 2, 2025 at 2:30 PM (IST). The presentation was uploaded to the company website as required under Regulation 46(2)(o) of the SEBI Listing Regulations. The filing is a cover letter to NSE and BSE; the pages provided do not include the presentation's financial figures or management commentary. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 30 Apr 2025 | board outcome Acquisition, Capex, Dividend / buy-back, Legal, Results | Coromandel International Limited has informed the Exchange regarding Outcome of Board Meeting held on April 30, 2025.AI summaryCoromandel International Board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2025 (statutory auditor S R Batliboi & Associates). Board declared final dividend of Rs. 6/- per equity share (face value Re. 1/-) plus special dividend of Rs. 3/- per equity share; record date July 17, 2025; payment on or before August 23, 2025. 63rd Annual General Meeting convened for July 24, 2025. Board approved appointment of Sridharan & Sridharan Associates as Secretarial Auditors for five years from FY 2025-26 to FY 2029-30, subject to shareholder approval. Company approved corporate guarantee up to USD 21 million for Baobab Mining & Chemicals Corporation, Senegal; BMCC's stake acquired by subsidiary Coromandel Chemicals Limited (additional 8.82% for Rs. 33.29 crore, taking stake above existing 45%), and BMCC ceases to be an associate and becomes a subsidiary upon satisfactory completion of conditions. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 30 Apr 2025 | dividend Acquisition, Capex, Dividend / buy-back, Legal, Results | Coromandel International Limited has informed the Exchange that Board of Directors at its meeting held on April 30, 2025, recommended Final Dividend of 9 per equity share.AI summaryCoromandel International's board approved audited financial results for the quarter and year ended March 31, 2025 on April 30, 2025. The board approved a final dividend of Rs. 6 per equity share (face value Re. 1) and a special dividend of Rs. 3 per equity share, with record date July 17, 2025 and payment on or before August 23, 2025. The 63rd Annual General Meeting is convened for July 24, 2025. The board approved a corporate guarantee of up to USD 21 million for Baobab Mining & Chemicals Corporation, Senegal, and an additional 8.82% stake purchase (Rs. 33.29 crore) in BMCC, which is to become a subsidiary on satisfactory completion of conditions. The board approved equity infusion of up to Rs. 65 crore in wholly owned subsidiary Coromandel Chemicals Limited for gypsum-based building material joint ventures. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 25 Mar 2025 | credit rating Rating | Coromandel International Limited has informed the Exchange about Credit RatingAI summaryCoromandel International Limited filed a Regulation 30 disclosure dated March 25, 2025 on credit rating re-affirmation. CRISIL, in an announcement dated March 24, 2025, re-affirmed its long-term bank loan rating at CRISIL AAA/Stable for facilities rated Rs. 9500 Crores. CRISIL also re-affirmed the short-term bank loan rating at CRISIL A1+. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 12 Mar 2025 | board outcome Acquisition, Legal | Coromandel International Limited has informed the Exchange regarding Outcome of Board Meeting held on March 12, 2025.AI summaryCoromandel International's board approved on March 12, 2025 the acquisition of 10,68,96,146 equity shares of NACL Industries Limited, representing 53.13% of its paid-up equity share capital, from promoters and promoter group under a Promoter SPA. The filing also covers purchase of 5,500 shares each from two public shareholders (Krishi Rasayan Exports Private Limited and M/s. Agro Life Science Corporation), totalling 11,000 shares or 0.01% of NACL's equity; all three SPAs were executed on March 12, 2025. The price is INR 76.70 per equity share, paid in cash; the company states it will acquire control of the target and must make an open offer under the SEBI Takeover Regulations. The transaction is subject to approval of the Competition Commission of India; completion of the acquisition and open offer is expected by end of Q1/Q2 of FY2025-26. NACL's consolidated turnover for FY ended March 31, 2024 was INR 1,787 crores; the company says the deal will make Coromandel a leading Indian crop protection player and expand its contract manufacturing and product portfolio. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 06 Feb 2025 | transcript Capex, Dividend / buy-back, Results | Coromandel International Limited has informed the Exchange about TranscriptAI summaryCoromandel International filed the transcript of its Q3 FY'25 earnings conference call held on January 31, 2025, uploaded to its website under Regulation 46(2)(oa)(ii) of the SEBI LODR Regulations. Management said Q3 consolidated total income was Rs. 7,049 crores (up 28% year on year) and 9-month total income was Rs. 19,330 crores (up 6%); quarterly EBITDA was Rs. 722 crores against Rs. 358 crores, and quarterly net profit was Rs. 508 crores against Rs. 228 crores. Management said NPK primary sales in Q3 were 11.4 lakh tons against 9.4 lakh tons, and the Kakinada 7.5 lakh ton NPK project is expected to commence commercial production from Q4 2027. Management announced an interim dividend of Rs. 6 per share, approved by the Board on January 30, 2025. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 31 Jan 2025 | presentation Results | Coromandel International Limited has informed the Exchange about Investor PresentationAI summaryCoromandel International has filed its investor presentation for the conference call on January 31, 2025 at 2:30 PM (IST) to discuss Q3FY25 results for the quarter ended December 31, 2024. The presentation has been uploaded to the company website, as required under Regulation 46(2)(o) of the SEBI LODR Regulations, 2015. The filing itself contains no financial figures or management commentary; the cover letter is signed by the Company Secretary and Compliance Officer. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 30 Jan 2025 | results Results | Integrated Filing (Financial) for the quarter and nine months ended 31 December 2024.AI summaryCoromandel International submitted its Integrated Filing (Standalone and Consolidated Financials) for the quarter and nine months ended December 31, 2024, under SEBI Circular dated December 31, 2024. The filing is a cover letter to NSE and BSE requesting acknowledgement and record. The pages provided do not contain the financial figures, revenue, profit or management commentary. Statements on proceeds deviation, debt defaults, related party transactions and audit qualifications are marked not applicable. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 30 Jan 2025 | results Acquisition, Dividend / buy-back, Legal, Results | Coromandel International Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024.AI summaryCoromandel International filed its unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2024, approved by the Board on January 30, 2025 with a limited review report from S R Batliboi & Associates. Standalone revenue from operations for the quarter ended December 31, 2024 was Rs 6,925.83 crore, and standalone profit after tax was Rs 523.10 crore for the quarter (figures as read from the OCR text). The Board declared an interim dividend for FY 2024-25 of Rs 6 per equity share (600% on face value of Re 1), payable on or after February 19, 2025, with record date February 5, 2025. The Board approved setting up a wholly owned subsidiary in the Netherlands with investment of up to EUR 1,00,000. The Board approved a corporate guarantee of up to USD 11 million in favour of banks for working capital facilities of associate Baobab Mining & Chemicals Corporation, Senegal. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 30 Jan 2025 | dividend Acquisition, Dividend / buy-back, Legal, Results | Coromandel International Limited has informed the Exchange that Board of Directors at its meeting held on January 30, 2025, declared Interim Dividend of 6 per equity share.AI summaryCoromandel International filed the outcome of its January 30, 2025 board meeting: unaudited standalone and consolidated results for the quarter and nine months ended December 31, 2024, with a limited review report from S R Batliboi & Associates. The board declared an interim dividend of Rs 6 per equity share (600% on face value of Re 1), payable on or after February 19, 2025, with record date February 5, 2025. The board approved setting up a wholly owned subsidiary in the Netherlands with investment of up to EUR 1,00,000. The board approved a corporate guarantee of up to USD 11 million in favour of banks for working capital facilities of Baobab Mining & Chemicals Corporation, Senegal, an associate company. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 16 Dec 2024 | presentation | Coromandel International Limited has informed the Exchange about Investor PresentationAI summaryCoromandel International filed the investor presentation made at its investor and analyst meet held on December 16, 2024. The presentation has been uploaded to the company's website, as required under Regulation 46(2)(o) of the SEBI LODR Regulations, 2015. The filing is a cover letter from the Company Secretary, B. Shanmugasundaram; the pages provided do not include the presentation's financial figures or management commentary. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
The list of announcements the National Stock Exchange publishes for the company; each link opens the exchange's own copy. Ask Sensei searches these filings when a question names the company.